- Home
- NEO vs NMM Comparison
NEO vs NMM Comparison
Compare NEO & NMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- NMM
- Stock Information
- Founded
- NEO 2001
- NMM 2007
- Country
- NEO United States
- NMM Greece
- Employees
- NEO N/A
- NMM N/A
- Industry
- NEO Precision Instruments
- NMM Marine Transportation
- Sector
- NEO Health Care
- NMM Consumer Discretionary
- Exchange
- NEO Nasdaq
- NMM Nasdaq
- Market Cap
- NEO 1.2B
- NMM 1.3B
- IPO Year
- NEO 1999
- NMM 2007
- Fundamental
- Price
- NEO $10.21
- NMM $47.21
- Analyst Decision
- NEO Buy
- NMM
- Analyst Count
- NEO 10
- NMM 0
- Target Price
- NEO $12.56
- NMM N/A
- AVG Volume (30 Days)
- NEO 5.6M
- NMM 96.8K
- Earning Date
- NEO 10-28-2025
- NMM 11-04-2025
- Dividend Yield
- NEO N/A
- NMM 0.42%
- EPS Growth
- NEO N/A
- NMM N/A
- EPS
- NEO N/A
- NMM 10.24
- Revenue
- NEO $709,162,000.00
- NMM $1,305,026,000.00
- Revenue This Year
- NEO $10.40
- NMM N/A
- Revenue Next Year
- NEO $10.11
- NMM $9.93
- P/E Ratio
- NEO N/A
- NMM $4.61
- Revenue Growth
- NEO 10.10
- NMM N/A
- 52 Week Low
- NEO $4.72
- NMM $28.37
- 52 Week High
- NEO $19.12
- NMM $56.70
- Technical
- Relative Strength Index (RSI)
- NEO 60.50
- NMM 58.60
- Support Level
- NEO $9.83
- NMM $45.66
- Resistance Level
- NEO $11.41
- NMM $47.10
- Average True Range (ATR)
- NEO 0.48
- NMM 1.22
- MACD
- NEO -0.05
- NMM 0.29
- Stochastic Oscillator
- NEO 48.03
- NMM 88.77
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About NMM Navios Maritime Partners LP Common Units Representing Limited Partner Interests
Navios Maritime Partners LP is a seaborne shipping company. It owns and operates dry cargo and container vessels with the primary long-term and staggered expiration charters. The firm's fleet consists of Ultra- Handymax, Panamax, Capsize, and Container vessels and categorized in Drybulk and Container vessels. It earns revenue through the chartering of vessels and voyage contracts. Geographically, it generates majority revenue from Asia.